WP1 focuses on the development of an integrated bioinformatics platform that functions as a repository of clinical data, biomarker data, images, as well as storage of bio-tissues from a broad spectrum of OA patients.
WP2 focuses on, proteomics, metabolomics and lipidomics analyses to identify novel and current (validated) markers for validation and qualification.
WP3 covers different OA aetiologies (phenotypes) in numbers that fulfil basic requirements for further statistical and bioinformatics studies, which will be performed in WP1.
WP4 is the consortium management layer, which will ensure optimal collaboration between partners and relevant stakeholders, and knowledge exchange between the WPs.